HopeStage
Back to all studies
CompletedNCT01793129

Preemie Hypothermia for Neonatal Encephalopathy

Device studyAges 33–35 weeksUnited StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: 33 weeks to 35 weeks.

Listed locations
Birmingham and 17 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2015
Recruitment status
Completed
Enrollment listed in the registry
168
Sponsor
NICHD Neonatal Research Network
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device, Procedure
Locations
United States
Age range
From 33 Weeks to 35 Weeks
Official registry ID
NCT01793129
Official title
Show the full official title

A Randomized Trial of Targeted Temperature Management With Whole Body Hypothermia For Moderate And Severe Hypoxic-Ischemic Encephalopathy In Premature Infants 33-35 Weeks Gestational Age.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham · Palo Alto · Atlanta

14 more locations
  • Indianapolis
  • Iowa City
  • Detroit
  • Albuquerque
  • Rochester
  • Durham
  • Cincinnati
  • Cleveland
  • Columbus
  • Philadelphia
  • Providence
  • Dallas
  • Houston
  • Salt Lake City

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is NICHD Neonatal Research Network.

Who was this study for?

Listed age limits: 33 weeks to 35 weeks.

Want to explore more studies?

Explore studies